FDA Drug Recalls

Recalls / Class III

Class IIID-0633-2024

Product

Hydrocortisone 1% & Acetic Acid 2% Otic Solution, 10 mL bottle, Rx only, Mfg by: Taro Pharmaceuticals, Inc., Brampton, Ontario, Canada L6T 1C1, Distributed by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, NDC 51672-3007-01

Affected lot / code info
Lot # AD12890, Exp 09/30/2024

Why it was recalled

Failed Impurities/Degradation Specifications: Out-of-specification results obtained for related impurities and slightly lower than the established level of the Hydrocortisone Assay obtained during stability testing.

Recalling firm

Firm
Taro Pharmaceuticals U.S.A., Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
3 Skyline Dr, Hawthorne, New York 10532-2174

Distribution

Quantity
96 vials
Distribution pattern
Product was distributed to one distributor

Timeline

Recall initiated
2024-08-07
FDA classified
2024-08-13
Posted by FDA
2024-08-21
Status
Completed

Source: openFDA Drug Enforcement endpoint. Recall record D-0633-2024. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class III recall: drug · FDA Drug Recalls